Seamless compilation of Module 3 Quality (CMC) technical dossiers in eCTD format, impurity qualification, and regulatory agency audit representation.
Preparation of Module 3 (CMC) quality dossiers for ANDA, NDA, MAA, and CDSCO Form 29/44 applications.
Method alignment and monograph gap analysis across Indian (IP), United States (USP), British (BP), and European (EP) pharmacopoeias.
Structure elucidation, toxicity threshold determination (TTC), and ICH Q3A/B impurity qualification reports.
Type II Drug Master File (DMF) technical writing, LOA issuance assistance, and annual update management.
Expert scientific response drafting for CDSCO queries, DCA regulatory reviews, and international health authority validation questions.
Designing and executing ICH Q1A(R2) stability protocols for Zone IVb submission packages.